OSP News

Stelara IV Biosimilars Added to Medicaid Coverage

Posted: 07/03/2025

The following coverage changes are in process for Stelara® IV and Stelara IV biosimilars under the medical benefit for Priority Health Medicaid members:

  • Effective June 1, the below Stelara IV biosimilars were added to coverage under the medical benefit for Medicaid members:
    • Otulfi® IV (ustekinumab-aauz)
    • Pyzchiva® IV (ustekinumab-ttwe)
    • Selarsdi™ IV (ustekinumab-aekn)
    • Steqeyma® IV (ustekinumab-stba)
    • Ustekinumab IV (unbranded Stelara)
    • Yesintek (ustekinumab-kfce)
  • Effective August 1, Stelara IV will be removed from coverage under the medical benefit for our Medicaid members.

Click here to read the full announcement from Priority Health.

We value your privacy. We use cookies and other technologies to keep the web site reliable and secure, tailor your experience, and measure web site performance, as described in our Privacy Policy.

x

OSP Technical Support